Hu. Strohmenger et al., CONCENTRATIONS OF PROLACTIN AND PROSTAGLANDINS DURING AND AFTER CARDIOPULMONARY-RESUSCITATION, Critical care medicine, 23(8), 1995, pp. 1347-1355
Objectives: To assess differences in plasma prolactin and prostaglandi
n concentrations in resuscitated and nonresuscitated patients during c
ardiopulmonary resuscitation (CPR), and to compare changes of prostagl
andin and prolactin concentrations with hemodynamic variables in the i
mmediate postresuscitation phase. Design: Prospective, descriptive stu
dy. Setting: Emergency medical service at a university hospital. Patie
nts: Twenty-nine patients ranging in age from 39 to 87 yrs with out-of
-hospital cardiac arrest. Interventions: Venous blood samples were tak
en during CPR and at 5, 15, 30, and 60 mins after restoration of spont
aneous circulation in order to measure plasma concentrations of prolac
tin, prostaglandin F-2 alpha, 15-keto-13,14-dihydro-prostaglandin F-2
alpha, 6-keto-prostaglandin F-2 alpha, and thromboxane B-2 by immunoas
say. Heart rate and blood pressure were measured at 5, 15, 30, and 60
mins after restoration of spontaneous circulation. Measurements and Ma
in Results: In 15 patients, restoration of spontaneous circulation was
achieved; in the remaining 14 patients, successful resuscitation was
not possible. During CPR, the mean plasma prolactin, prostaglandin F-2
alpha, 15-keto-13,14-dihydro-prostaglandin F-2 alpha, 6-keto-prostagl
andin F-2 alpha, and thromboxane B-2 concentrations were 95.9 +/- 13.6
mu g/L, 357 +/- 61 ng/L, 228 +/- 28 ng/L, 277 +/- 66 ng/L, and 375 +/
- 78 ng/L, respectively, in resuscitated patients, and 23.9 +/- 5.6 mu
g/L (p = .0001), 192 +/- 22 ng/L (p = .005), 202 +/- 31 ng/L (p = .52
8), 221 +/- 40 ng/L (p = .713), and 344 +/- 77 ng/L (p = .780), respec
tively, in nonresuscitated patients. At 60 mins after restoration of s
pontaneous circulation, the mean plasma prolactin, prostaglandin F-2 a
lpha, 15-keto-13,14-dihydro-prostaglandin F-2 alpha, 6-keto-prostaglan
din F-1 alpha, and thromboxane B-2 concentrations were 50.1 +/- 9.5 mu
g/L, 306 +/- 42 ng/L, 503 +/- 87 ng/L, 278 +/- 55 ng/L, and 355 +/- 3
0 ng/L, respectively. Mean values of systolic arterial blood pressure
were 114 +/- 12 mm Hg at 30 mins and 123 +/- 18 mm Hg at 60 mins. No s
ignificant correlations were found between hemodynamic values and plas
ma concentrations of prolactin or prostaglandins. Conclusions: Prolact
in and prostaglandin concentrations were increased during cardiac arre
st and CPR. Successful initial resuscitation was associated with incre
ased prolactin and prostaglandin F-2 alpha concentrations during CPR.
Decreased concentrations in nonresuscitated patients may have been a r
esult of exhaustion of the neuroendocrine and eicosanoid systems, or m
ay be due to differences in bioavailability at the site of blood sampl
ing based upon differences in hemodynamics.